Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 13 studies | 29% ± 7% | |
oligodendrocyte | 12 studies | 37% ± 11% | |
glutamatergic neuron | 11 studies | 57% ± 23% | |
smooth muscle cell | 8 studies | 31% ± 11% | |
astrocyte | 8 studies | 30% ± 9% | |
GABAergic neuron | 7 studies | 45% ± 24% | |
endothelial cell | 6 studies | 25% ± 11% | |
retinal bipolar neuron | 5 studies | 45% ± 18% | |
neuron | 4 studies | 39% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 4% | |
interneuron | 4 studies | 51% ± 19% | |
GABAergic interneuron | 3 studies | 35% ± 9% | |
OFF-bipolar cell | 3 studies | 19% ± 1% | |
ON-bipolar cell | 3 studies | 32% ± 1% | |
Mueller cell | 3 studies | 22% ± 3% | |
rod bipolar cell | 3 studies | 85% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 6879.66 | 2636 / 2642 | 97% | 72.10 | 684 / 705 |
kidney | 80% | 576.85 | 71 / 89 | 82% | 34.82 | 739 / 901 |
pancreas | 98% | 928.19 | 322 / 328 | 63% | 8.89 | 113 / 178 |
breast | 70% | 533.04 | 323 / 459 | 88% | 40.83 | 982 / 1118 |
thymus | 53% | 286.32 | 346 / 653 | 91% | 14.86 | 553 / 605 |
adrenal gland | 24% | 125.60 | 63 / 258 | 89% | 70.10 | 205 / 230 |
uterus | 57% | 290.51 | 97 / 170 | 51% | 12.25 | 233 / 459 |
prostate | 22% | 93.78 | 55 / 245 | 83% | 21.04 | 416 / 502 |
stomach | 66% | 354.56 | 236 / 359 | 35% | 3.73 | 100 / 286 |
lung | 23% | 102.10 | 131 / 578 | 71% | 16.67 | 824 / 1155 |
blood vessel | 92% | 746.17 | 1222 / 1335 | 0% | 0 | 0 / 0 |
skin | 8% | 35.62 | 145 / 1809 | 68% | 21.91 | 320 / 472 |
ovary | 34% | 150.45 | 61 / 180 | 41% | 5.73 | 175 / 430 |
adipose | 65% | 425.56 | 787 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 9.73 | 28 / 45 |
esophagus | 19% | 81.79 | 268 / 1445 | 38% | 3.95 | 70 / 183 |
spleen | 56% | 246.45 | 136 / 241 | 0% | 0 | 0 / 0 |
bladder | 24% | 87.19 | 5 / 21 | 31% | 6.17 | 157 / 504 |
intestine | 22% | 102.91 | 213 / 966 | 29% | 4.46 | 155 / 527 |
lymph node | 0% | 0 | 0 / 0 | 48% | 7.16 | 14 / 29 |
liver | 0% | 0 | 0 / 226 | 41% | 8.79 | 168 / 406 |
eye | 0% | 0 | 0 / 0 | 35% | 4.49 | 28 / 80 |
heart | 23% | 103.21 | 196 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 34.51 | 77 / 929 | 0% | 0 | 0 / 0 |
muscle | 4% | 16.30 | 32 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0007417 | Biological process | central nervous system development |
GO_0043204 | Cellular component | perikaryon |
GO_0005615 | Cellular component | extracellular space |
GO_0060205 | Cellular component | cytoplasmic vesicle lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | SERPINI1 |
Protein name | Serpin peptidase inhibitor clade I member 1 isoform 2 Neuroserpin (Peptidase inhibitor 12) (PI-12) (Serpin I1) Serpin family I member 1 Serpin peptidase inhibitor clade I member 1 isoform 1 |
Synonyms | PI12 |
Description | FUNCTION: Serine protease inhibitor that inhibits plasminogen activators and plasmin but not thrombin . May be involved in the formation or reorganization of synaptic connections as well as for synaptic plasticity in the adult nervous system. May protect neurons from cell damage by tissue-type plasminogen activator (Probable). . |
Accessions | ENST00000446050.7 H7C5T9 ENST00000466865.1 ENST00000472941.5 C9JDY5 A0A0S2Z455 A0A0S2Z463 ENST00000295777.9 ENST00000472747.2 Q99574 C9JQU8 |